5,9-dimethyl-4,8-decadienal

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

December 09, 1980 - December 23, 1980

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

comparable to guideline study with acceptable restrictions

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1981

Report date:

1981

Materials and methods

Test guideline

Qualifier:

equivalent or similar to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

Deviations:

yes

Remarks:

Limited details on test material, no purity.

GLP compliance:

yes

Test type:

standard acute method

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

(4E)-5,9-dimethyldeca-4,8-dienal

Cas Number:

18445-88-0

Molecular formula:

C12H20O

IUPAC Name:

(4E)-5,9-dimethyldeca-4,8-dienal

Constituent 2

Reference substance name:

(4Z)-5,9-dimethyldeca-4,8-dienal

Cas Number:

18445-81-3

Molecular formula:

C12H20O

IUPAC Name:

(4Z)-5,9-dimethyldeca-4,8-dienal

Test animals

Species:

rat

Strain:

other: TAC:N(SD)fBR

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Taconic Farms, Inc.
- Age at study initiation: No data
- Weight at study initiation: males: 200 - 244g; females: 151 - 172g
- Fasting period before study: fasted overnight prior to dosing
- Housing: Animals were individually housed in stainless steel cages with wire-mesh floors
- Diet: Free access to Purina Rodent Laboratory Chow 5001
- Water: Free access to filtered tap water
- Acclimation period: 13 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data
- Humidity (%): No data
- Air changes (per hr): 14
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: December 9, 1980 To: December 23, 1980

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

unchanged (no vehicle)

Details on oral exposure:

Individual doses, calculated on the basis of bodyweight and the dose level (mL), were administered via oral intubation tube.

Doses:

0.59, 1.00, 1.69, 2.88 and 5.00 mL/kg bw

No. of animals per sex per dose:

5

Control animals:

no

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations: The animals were observed frequently during the first 5 hours after dosing and twice daily thereafter
- Necropsy of survivors performed: yes, at the end of the observation period the animals were killed by CO2 asphyxia, necropsied and subjected to examination for gross pathological changes.
- Body weights: Individual body weights were recorded immediately before treatment and then on the 14th day of the observation period or at time of death if prior to scheduled sacrifice on day 14

Results and discussion

Effect levels

Key result

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 5 000 mg/kg bw

Based on:

test mat.

Mortality:

One male animal dosed at 5 mL/kg bw was found dead on day 1. All other animals survived for the duration of the study.

Gross pathology:

The gross lesions found at necropsy were interpreted to be incidental findings unrelated to test article administration.

Applicant's summary and conclusion

Interpretation of results:

other: Not classified.

Remarks:

According to Regulation (EC) No. 1272/2008 and its amendments.

Conclusions:

The acute oral toxicity test with the substance showed an LD50 of > 5000 mg/kg bw.

Executive summary:

Acute oral toxicity: In this study equivalent to OECD TG 401 and in compliance with GLP principles, 10 rats (5 males and 5 females) were administered the substance at dose levels of0.59, 1.00, 1.69, 2.88 and 5.00 mL/kg bw, resulting in the highest dose of 5000 mg/kg bw. The doses are not adjusted for density because it does not affect the study result for C&L (LD50 > 4376 mg/kg bw using relative density of 0.8753). One male animal dosed at 5 mL/kg bw was found dead on day 1. Clinical signs observed included diarrhea, salivation, lethargy, crusty nose, crusty eyes, lacrimation and loose stool and were suggestive of cholinergic-like action. The incidence of diarrhea increased with dose level.The gross lesions foundat necropsy were interpreted to be incidental findings unrelated to substance administration. The acute oral LD50 for the substance in male and female rats was determined to be > 5 000 mg/ kg bw, so it is not classified.